Markku Jalkanen

}} Markku Jalkanen (born 1954) is a scientist, biotech entrepreneur and businessman from Turku, Finland. He is the CEO of Faron Pharmaceuticals, a Finnish biopharmaceutical company listed on London's Alternative Investment Market and Nasdaq's First North Growth Market. Jalkanen was the founding CEO and President of Biotie Therapies, the first publicly traded biotech-company in Finland. He is an advisor for the Finnish life-science fund, Inveni Capital. Provided by Wikipedia
Showing 1 - 1 results of 1 for search 'Jalkanen, Markku'
query time: 0.01s Refine Results
  1. 1
    Izolovaný polynukleotid, izolovaný C5-epimerázový polypeptid, spôsob produkcie proteínu a spôsob zvýšenia aktivity C5-epimerázy /
    Patent

    Save to List
    Saved in:
Search Tools: RSS Feed – Save Search